Phosphoproteomics and RNA-Seq analyses identified a strong E2F response in treated cells and tumours, as well as key targets of ATR activity in response to replication stress in NB cells (including FANCD2, FANCI, ATRX and DCK). The gene discussed is DCK; the disease is neoplasm.